NV3-17355-39817
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 300 / GA
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Moderna
-
2021-03-09
Registered in v-safe
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Moderna
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Pulmonary pain — Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessFree text: Lung painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
-
2021-05-03
Survey response — day 21, dose 2MedDRA: Computerised tomogram, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Enlarged lympnodes on CT Scan requiring follow up in 4 weeks · Healthcare visit (other): Follow up with additional CT scan to confirm not related to cancerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-10
- 2021-05-17
-
2021-05-24
Survey response — day 42, dose 2MedDRA: Menstruation irregular — Feeling: GoodFree text: My typically consistent period started 10 days earlier than normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-12
-
2021-10-11
Survey response — 6 months, dose 2MedDRA: COVID-19, Medical counselling — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Covid 19 · Healthcare visit (other): In person doctor appointment in parking lotMedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-10-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-12 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Lung pain
Release 8 — day 21, dose 2
Symptoms: Enlarged lympnodes on CT Scan requiring follow up in 4 weeks
Healthcare visit (other): Follow up with additional CT scan to confirm not related to cancer
Release 8 — day 42, dose 2
Symptoms: My typically consistent period started 10 days earlier than normal.
Release 10 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Computerised tomogram | ✓ | ✓ | ✓ |
| HCVO | Medical counselling | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Pulmonary pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release